The HOOK2 Knockout NCI-H1975 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population designed for loss-of-function studies of the HOOK2 gene. This product consists of a heterogeneous pool of NCI-H1975 cells harboring targeted genetic disruptions at the HOOK2 locus, generated via CRISPR/Cas9-mediated gene disruption. The polyclonal format provides a representative knockout model without single-cell clonal selection, enabling researchers to investigate HOOK2 function in a biologically diverse cell population. This model is suitable for experiments requiring bulk knockout effects, such as population-level endosomal trafficking assays or drug sensitivity screens.
The parental NCI-H1975 cell line is a widely used human lung adenocarcinoma epithelial model derived from the pleural effusion of a female patient. These cells harbor clinically relevant EGFR mutations (L858R and T790M) and a TP53 mutation, making them an important tool for studying non-small cell lung cancer (NSCLC) biology, particularly resistance to first- and second-generation EGFR tyrosine kinase inhibitors. The L858R mutation confers increased kinase activity, while the T790M gatekeeper mutation confers resistance to many EGFR inhibitors, making NCI-H1975 cells valuable for investigating mechanisms of acquired drug resistance and evaluating next-generation therapeutics.
HOOK2 encodes a microtubule-binding protein that functions as a key adaptor linking the dynein-dynactin motor complex to endosomal compartments, thereby mediating retrograde transport along microtubules. HOOK2 interacts with HOOK3, FTS, dynein light chain, and dynactin to form the HOOK complex, which facilitates the movement of early (RAB5-positive, EEA1-positive) and late (RAB7-positive, LAMP1-positive) endosomes. This process is essential for endosomal maturation, cargo sorting, and receptor degradation. While upstream regulators remain undefined, HOOK2 activity may be influenced by EGFR signaling, given its role in the endocytic trafficking of receptor tyrosine kinases. Disruption of HOOK2 impairs dynein-mediated motility, leading to altered endosomal positioning and defective degradative trafficking.
In the context of NCI-H1975 cells, HOOK2 knockout is particularly relevant for dissecting how endosomal dynamics affect EGFR receptor fate and signaling outputs. Mutant EGFR in these cells undergoes altered trafficking compared to wild-type, potentially contributing to sustained signaling and drug resistance. By eliminating HOOK2, researchers can assess whether impaired retrograde transport of EGFR-containing endosomes affects receptor degradation, downstream pathway activation (such as MAPK and AKT), and sensitivity to EGFR inhibitors. This model also enables investigation of the crosstalk between microtubule organization and endosomal trafficking in maintaining the oncogenic phenotype of lung adenocarcinoma.
The HOOK2 Knockout NCI-H1975 Polyclonal Cells can be employed in a variety of experimental workflows. Common applications include western blotting and RT-qPCR to confirm HOOK2 deficiency, immunofluorescence microscopy using EEA1 and LAMP1 markers to visualize endosomal distribution, co-immunoprecipitation to assess interactions with dynein or dynactin components, and live-cell imaging to track endosomal motility. Functional assays such as migration, invasion, and drug sensitivity profiling with EGFR inhibitors (e.g., osimertinib) can reveal the contribution of HOOK2 to metastatic behavior and therapeutic resistance. This knockout model is also suitable for ciliogenesis studies, given HOOK2??s role in microtubule organization. For further technical information, please contact Ascent Research.
